{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 4746"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Public Health Service Act to establish a program of research regarding the risks posed\n\t\t\t by the presence of dioxin, synthetic fibers, chemical fragrances, and\n\t\t\t other components of feminine hygiene products."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140528", "#text": "May 28, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, "sponsor": {"#tail": " (for herself, ", "#text": "Mrs. Carolyn B. Maloney of New York", "@name-id": "M000087"}, "cosponsor": [{"#tail": ", and ", "#text": "Mr. Farr", "@name-id": "F000030"}, {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Ms. Moore", "@name-id": "M001160"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H63F3AD4CA60E46419AAE944A750C3709", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Robin Danielson Act of 2014", "@value": "Robin Danielson Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "idCF38A0C08A3F4F3898022AADF8160EC5"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "The Congress finds as follows:", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Feminine hygiene products are widely used by women in the United States today, but there is not\n\t\t\t enough research on the components of these products."}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "HB379D212ED5A4C8299BC8E15267C72BB", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Women may be exposed to substances in tampons and other menstrual products for as long as 60 years\n\t\t\t over the course of their reproductive lives. The average woman may use as\n\t\t\t many as 16,800 tampons in her lifetime. A woman on menopausal hormone\n\t\t\t therapy may use as many as 24,360 tampons in her lifetime."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "H30E8D50879B94E218D08932B63022418", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and the ", "@entity-type": "federal-body", "#text": "Environmental Protection Agency", "@entity-id": "6800"}, {"#tail": ", an arm of the ", "@entity-type": "federal-body", "#text": "International Agency for Research\n\t\t\t on Cancer", "@entity-id": "19EC"}, {"#tail": ", have concluded that\n\t\t\t dioxins are a probable human carcinogen (cancer-causing agent).", "@entity-type": "federal-body", "#text": "World Health Organization", "@entity-id": "19UH"}], "#text": "Trace amounts of dioxins can be found in tampons or other feminine hygiene products. The\n\t\t\t "}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "H306DD3F077DF409D9364817D39E7CF1C", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (referred to in this section as the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "The ", "quote": {"#tail": ") has historically relied on data provided by manufacturers of feminine hygiene products in\n\t\t\t determining product safety.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "federal-body", "#text": "FDA", "@entity-id": "7524"}, "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "HF807ABE65CF542988A6E8C05C0874852", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " currently requires tampon manufacturers to routinely monitor dioxin levels in raw\n\t\t\t materials and finished tampons, this information is not readily available\n\t\t\t to the public. The ", "@entity-type": "federal-body", "#text": "FDA", "@entity-id": "7524"}, {"#tail": " should consider whether to expand regulation to\n\t\t\t include other types of feminine hygiene products and a broader list of\n\t\t\t contaminants.", "@entity-type": "federal-body", "#text": "FDA", "@entity-id": "7524"}], "#text": "Although the "}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "HD4860DE875084F01867F8A92A17E2A8D", "#text": "\n        "}], "#text": "\n      ", "@id": "HCBE4CFAE71114C39BBE04D6131FF0FB1"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding\n\t\t\t at the end the following section:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Part F of title IV of the Public Health Service Act", "@value": "Public Health Service Act/t:IV/pt:F"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "42 U.S.C. 287d et seq.", "@value": "usc/42/287d/etseq"}, "@parsable-cite": "usc/42/287d", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Research on dioxin and other potentially harmful components of feminine hygiene products"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "486C."}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Research on dioxin and other potentially harmful components of feminine hygiene products"}, "subsection": [{"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Research"}, "paragraph": [{"#tail": "\n            ", "@id": "HB8B0C741284B4D4DA06702E9BE108A1C", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", in collaboration with the ", "@entity-type": "federal-body", "#text": "Director of NIH", "@entity-id": "7529"}, {"#tail": ", shall provide for the\n\t\t\t conduct or support of research to determine the extent to which the\n\t\t\t presence of dioxins, synthetic fibers, chlorine, and other components,\n\t\t\t including contaminants and substances used as fragrances, in tampons and\n\t\t\t other feminine hygiene products\u2014", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "Director of the Office", "@value": "Office of Research on Women\u2019s Health"}], "#text": "The "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "poses any risks to the health of women who use the products, including risks relating to cervical\n\t\t\t cancer, endometriosis, infertility, ovarian cancer, breast cancer, immune\n\t\t\t system deficiencies, pelvic inflammatory disease, toxic shock syndrome,\n\t\t\t and bacterial and yeast infections; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H6888EB7FA0E44508B25068A593601F86", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "poses any risks to the health of children of women who used such products during or before the\n\t\t\t pregnancies involved, including risks relating to fetal and childhood\n\t\t\t development."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H2C27E883AE1C422CBDC24CE4BFC4733F", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall include research to confirm the data on tampons and other\n\t\t\t feminine hygiene products submitted to the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Public Health Service Act/s:486C/ss:a/p:1", "@proposed": "true"}, {"#tail": "\n\t\t\t by manufacturers of such products.", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}], "#text": "Research under "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Requirement regarding data from manufacturers"}, "#text": "\n              ", "@id": "H4B4AD6A242904B59AFB131180F41CD4C"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the term ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Public Health Service Act/s:486C/ss:a/p:1", "@proposed": "true"}, "#text": "For purposes of ", "quote": {"#tail": " means tampons, pads, liners, cups, sponges, and similar products used by women with respect to\n\t\t\t menstruation or other genital-tract secretions.", "#text": "feminine hygiene products"}}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Definition"}, "#text": "\n              ", "@id": "H721F164A4AE34C3FBC5F0B8C427980AA"}], "#text": "\n            ", "@id": "H04240F86E28944F7BE443012B3C85806"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be periodically submitted to the\n\t\t\t ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Public Health Service Act/s:486C/ss:a", "@proposed": "true"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}, {"#tail": ", and the ", "@entity-type": "federal-body", "#text": "Administrator of the\n\t\t\t Environmental Protection Agency", "@entity-id": "6800"}, {"#tail": ". Such reports shall be made available to the public\n\t\t\t through the data system and clearinghouse program established under\n\t\t\t ", "@entity-type": "federal-body", "#text": "Chairman of the Consumer Product\n\t\t\t Safety Commission", "@entity-id": "6100"}, {"#tail": ", or through other appropriate means.", "@entity-type": "act", "#text": "section 486A", "@value": "Public Health Service Act/s:486A"}], "#text": "Reports on the results of research under "}, "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "Reports"}, "#text": "\n            ", "@id": "H7E9A57B04E83473BA47192790976BBBB"}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ".", "#text": "such sums as\n\t\t\t may be necessary for each of the fiscal years 2015 through 2019", "@amount": "indefinite", "@year": "2015, 2016, 2017, 2018, 2019"}, "@entity-type": "auth-auth-approp", "#text": "\n                ", "{http://namespaces.cato.org/catoxml}property": {"#tail": ", there are authorized to be appropriated ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "this section", "@value": "Public Health Service Act/s:486C", "@proposed": "true"}, "#text": "For the purpose of carrying out ", "@name": "purpose"}}}, "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n            ", "#text": "Authorization of appropriations"}, "#text": "\n            ", "@id": "H2BFC734A51AB4BDDA1498553DCA3368C"}], "#text": "\n          ", "@id": "HC93BFE6315984CC8A8BBBE4AF2551F97"}, "#text": "\n\t\t\t\t", "@id": "HAD5D4C7105FC4824B0F195D3DFC04198"}, "#text": "\n      ", "@id": "H4E921B94866E475AB7A6C6D909A9CD3A"}], "#text": "\n\t\t", "@id": "H97112CB60F5D4461B4A6B140B2A33C1D"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-05-28"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4746 IH: Robin Danielson Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}